CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges

CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges

CanSino Biologics Inc. (OTC: CASBF), a Chinese vaccine maker, has emerged as the rising star of the Hong Kong market, after its COVID-19 clinical trial application was approved by Health Canada, the country's federal health policy department.CanSino Biologics' shares rose 380% in 2020, making it the darling of Hong Kong investors. The shares have outperformed all others with a market capitalization in excess of $2 billion in recent days, reported Fortune.What Happened The gains seen in CanSino have led to a word of caution from an expert. Castor Pang, head of research at Core Pacific-Yamaichi International Hong Kong, told Fortune, "No one knows how much CanSino is worth." Pang warned, "People are making bets on the success of its vaccine, but the trial is just in stage two and there is possibility for it to fail."Why It Matters Health care stocks are performing well in Hong Kong this year, with AK...

While U.S. economy slides, heartland auto dealers cry out for more trucks

Jerry Bill is worried the novel coronavirus could hurt business at the Des Moines auto dealership he runs, but not because of a shortage of buyers for the big Ram pickups on his lot. "Our biggest issue will be if we don't get more inventory," said Bill, general sales manager of Stew Hansen Chrysler Dodge Jeep Ram, which sells around 2,700 new vehicles a year in Urbandale, a suburb of Iowa's capital Des Moines. After a drop in sales in April when consumers stayed home, Bill expects pickup truck sales to end May similar to where they were a year earlier....

Stocks, Futures Fall on Widening U.S.-China Rift: Markets Wrap

(Bloomberg) -- Stocks declined alongside U.S. equity futures on Thursday as deteriorating Sino-American ties cast a cloud over the recent rally in risk assets. Treasuries advanced with the dollar.The Stoxx Europe 600 Index fell, with all 19 sector groups in the red. Deutsche Lufthansa AG shares bucked the trend after the carrier said it was close to a multibillion-euro bailout deal from the German government. Contracts on the three main American equities gauges signaled a drop at the Wall Street open, a day after the U.S. Senate overwhelmingly passed a bill that could bar some Chinese companies from listing on American exchanges.President Donald Trump stoked tensions by tweeting criticism of Xi Jinping’s leadership, two days before the biggest Chinese political gathering of the year. Asian shares dipped along with the yuan in offshore trading, while the Australian dollar tumbled.Concern over resurgent U.S.-China tensions and global coronavirus cases reaching 5 million are...

Stocks, Futures Drop on Worsening U.S.-China Rift: Markets Wrap

(Bloomberg) -- Stocks declined alongside U.S. equity futures on Thursday as deteriorating Sino-American ties cast a cloud over the recent rally in risk assets. Treasuries advanced with the dollar.The Stoxx Europe 600 Index erased Wednesday’s gain, with all 19 sector groups in the red. Contracts on the three main American equities gauges signaled a drop at the Wall Street open, a day after the U.S. Senate overwhelmingly passed a bill that could bar some Chinese companies from listing on American exchanges.President Donald Trump stoked tensions by tweeting criticism of Xi Jinping’s leadership, two days before the biggest Chinese political gathering of the year. Asian shares dipped and the Australian dollar sank, though the offshore yuan held steady.Worries about resurgent U.S.-China tensions and global coronavirus cases reaching 5 million are dueling for investor attention with optimism over reopening economies and progress on vaccines. AstraZeneca Plc received more than $1 billion in U.S....